Bulletin
Investor Alert

Humana Inc.

NYS: HUM

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 20, 2022, 6:56 p.m.

HUM
/zigman2/quotes/203095337/composite

$

439.62

Change

0.00 0.00%

Volume

Volume 47,075

Quotes are delayed by 20 min

/zigman2/quotes/203095337/composite

Previous close

$ 432.00

$ 439.62

Change

+7.62 +1.76%

Day low

Day high

$426.24

$440.85

Open

52 week low

52 week high

$351.20

$472.68

Open

Company Description

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental plans such as Med...

Humana Inc. engages in the provision of health insurance services. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental plans such as Medicare, and State-based contracts. The Group and Specialty segment contains employer group fully-insured commercial medical products and specialty health insurance benefits marketed to individuals and groups, including dental, vision, military services and other supplemental health & voluntary insurance. The Healthcare Services segment offers services such as pharmacy solutions, provider services, clinical care, predictive modeling and informatics to other Humana businesses, as well as external health plan members, and other employers. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Valuation

P/E Current

18.53

P/E Ratio (with extraordinary items)

17.64

P/E Ratio (without extraordinary items)

20.46

Price to Sales Ratio

0.72

Price to Book Ratio

3.72

Price to Cash Flow Ratio

26.53

Enterprise Value to EBITDA

14.30

Enterprise Value to Sales

0.72

Efficiency

Total Asset Turnover

2.10

Liquidity

Current Ratio

1.62

Profitability

Operating Margin

4.41

Pretax Margin

4.01

Net Margin

3.51

Return on Assets

7.35

Return on Equity

19.68

Return on Total Capital

15.54

Capital Structure

Total Debt to Total Assets

29.55

Officers and Executives

Name Age Officer Since Title
Mr. Bruce Dale Broussard 58 2011 President
Ms. Susan M. Diamond 47 2006 Segment President-Home Business
Dr. Alefiyah Mesiwala - 2021 Chief Medical Officer
Mr. Sam Deshpande - 2017 SVP, Chief Risk & Technology Officer
Mr. Timothy S. Huval 55 2012 Chief Human Resources & Administrative Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/03/2022 Sam Deshpande
Chief Information Officer
3,957   Disposition at $434.19 per share. 1,718,089
05/01/2022 William Shrank
Chief Medical Officer
164   Derivative/Non-derivative trans. at $449.81 per share. 73,768
05/01/2022 William Shrank
Chief Medical Officer
2,250   Derivative/Non-derivative trans. at $449.81 per share. 1,012,072
05/01/2022 William Shrank
Chief Medical Officer
504   Derivative/Non-derivative trans. at $0 per share. 0
05/01/2022 William Shrank
Chief Medical Officer
4,926   Derivative/Non-derivative trans. at $0 per share. 0
04/28/2022 Timothy S. Huval
Chief Administrative Officer
3,477   Disposition at $443.14 per share. 1,540,797
04/28/2022 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO
3,210   Disposition at $449.68 per share. 1,443,472
04/28/2022 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO
663   Gift at $0 per share. 0
03/15/2022 Timothy S. Huval
Chief Administrative Officer
439   Gift at $0 per share. 0
02/25/2022 Bruce Dale Broussard
President & CEO; Director
11,360   Derivative/Non-derivative trans. at $428.27 per share. 4,865,147
02/25/2022 Timothy Alan Wheatley
Segment President, Retail
2,363   Derivative/Non-derivative trans. at $428.27 per share. 1,012,002
02/25/2022 Cynthia H. Zipperle
SVP, Chief Acct Officer & Cont
427   Derivative/Non-derivative trans. at $428.27 per share. 182,871
02/25/2022 Heather Cox
Chief Dig Health & Analyt Off.
1,217   Derivative/Non-derivative trans. at $428.27 per share. 521,204
02/25/2022 Susan M. Diamond
Chief Financial Officer
437   Derivative/Non-derivative trans. at $428.27 per share. 187,153
02/25/2022 Timothy S. Huval
Chief Administrative Officer
1,707   Derivative/Non-derivative trans. at $428.27 per share. 731,056
02/25/2022 Sam Deshpande
Chief Information Officer
1,445   Derivative/Non-derivative trans. at $428.27 per share. 618,850
02/25/2022 Vishal Agrawal
Chief Strat & Corp Dev Officer
1,446   Derivative/Non-derivative trans. at $428.27 per share. 619,278
02/25/2022 Joseph C Ventura
Chief Legal Officer
888   Derivative/Non-derivative trans. at $428.27 per share. 380,303
02/25/2022 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO
2,079   Derivative/Non-derivative trans. at $428.27 per share. 890,373
02/25/2022 Bruce Dale Broussard
President & CEO; Director
29,754   Derivative/Non-derivative trans. at $0 per share. 0
02/25/2022 Timothy Alan Wheatley
Segment President, Retail
5,819   Derivative/Non-derivative trans. at $0 per share. 0
02/25/2022 Cynthia H. Zipperle
SVP, Chief Acct Officer & Cont
1,323   Derivative/Non-derivative trans. at $0 per share. 0
02/25/2022 Heather Cox
Chief Dig Health & Analyt Off.
3,967   Derivative/Non-derivative trans. at $0 per share. 0
02/25/2022 Susan M. Diamond
Chief Financial Officer
1,375   Derivative/Non-derivative trans. at $0 per share. 0
02/25/2022 Timothy S. Huval
Chief Administrative Officer
4,496   Derivative/Non-derivative trans. at $0 per share. 0
02/25/2022 Sam Deshpande
Chief Information Officer
3,967   Derivative/Non-derivative trans. at $0 per share. 0
02/25/2022 Vishal Agrawal
Chief Strat & Corp Dev Officer
3,967   Derivative/Non-derivative trans. at $0 per share. 0
02/25/2022 Joseph C Ventura
Chief Legal Officer
2,645   Derivative/Non-derivative trans. at $0 per share. 0
02/25/2022 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO
5,289   Derivative/Non-derivative trans. at $0 per share. 0
02/17/2022 Jorge S. Mesquita
Director
436   Derivative/Non-derivative trans. at $0 per share. 0
02/17/2022 Marcy S. Klevorn
Director
436   Derivative/Non-derivative trans. at $0 per share. 0
01/03/2022 David A. Jones
Director
412   Award at $0 per share. 0
01/03/2022 Marissa T. Peterson
Director
412   Award at $0 per share. 0
01/03/2022 James J. O'Brien
Director
412   Award at $0 per share. 0
01/03/2022 Jorge S. Mesquita
Director
412   Award at $0 per share. 0
01/03/2022 John W. Garratt
Director
412   Award at $0 per share. 0
12/15/2021 Bruce Dale Broussard
President & CEO; Director
970   Derivative/Non-derivative trans. at $459.85 per share. 446,054
12/15/2021 Bruce Dale Broussard
President & CEO; Director
1,052   Derivative/Non-derivative trans. at $459.85 per share. 483,762
12/15/2021 Bruce Dale Broussard
President & CEO; Director
1,199   Derivative/Non-derivative trans. at $459.85 per share. 551,360
12/15/2021 Timothy Alan Wheatley
Segment President, Retail
256   Derivative/Non-derivative trans. at $459.85 per share. 117,721
12/15/2021 Timothy Alan Wheatley
Segment President, Retail
266   Derivative/Non-derivative trans. at $459.85 per share. 122,320
12/15/2021 Timothy Alan Wheatley
Segment President, Retail
278   Derivative/Non-derivative trans. at $459.85 per share. 127,838
12/15/2021 Cynthia H. Zipperle
SVP, Chief Acct Officer & Cont
96   Derivative/Non-derivative trans. at $459.85 per share. 44,145
12/15/2021 Cynthia H. Zipperle
SVP, Chief Acct Officer & Cont
111   Derivative/Non-derivative trans. at $459.85 per share. 51,043
12/15/2021 Cynthia H. Zipperle
SVP, Chief Acct Officer & Cont
127   Derivative/Non-derivative trans. at $459.85 per share. 58,400
12/15/2021 Heather Cox
Chief Dig Health & Analyt Off.
130   Derivative/Non-derivative trans. at $459.85 per share. 59,780
12/15/2021 Heather Cox
Chief Dig Health & Analyt Off.
141   Derivative/Non-derivative trans. at $459.85 per share. 64,838
12/15/2021 Heather Cox
Chief Dig Health & Analyt Off.
160   Derivative/Non-derivative trans. at $459.85 per share. 73,576
12/15/2021 Susan M. Diamond
Chief Financial Officer
171   Derivative/Non-derivative trans. at $459.85 per share. 78,634
12/15/2021 Susan M. Diamond
Chief Financial Officer
133   Derivative/Non-derivative trans. at $459.85 per share. 61,160
12/15/2021 Susan M. Diamond
Chief Financial Officer
132   Derivative/Non-derivative trans. at $459.85 per share. 60,700
12/15/2021 Timothy S. Huval
Chief Administrative Officer
185   Derivative/Non-derivative trans. at $459.85 per share. 85,072
12/15/2021 Timothy S. Huval
Chief Administrative Officer
185   Derivative/Non-derivative trans. at $459.85 per share. 85,072
12/15/2021 Timothy S. Huval
Chief Administrative Officer
211   Derivative/Non-derivative trans. at $459.85 per share. 97,028
12/15/2021 Sam Deshpande
Chief Information Officer
158   Derivative/Non-derivative trans. at $459.85 per share. 72,656
12/15/2021 Sam Deshpande
Chief Information Officer
172   Derivative/Non-derivative trans. at $459.85 per share. 79,094
12/15/2021 Sam Deshpande
Chief Information Officer
184   Derivative/Non-derivative trans. at $459.85 per share. 84,612
12/15/2021 Vishal Agrawal
Chief Strat & Corp Dev Officer
148   Derivative/Non-derivative trans. at $459.85 per share. 68,057
12/15/2021 Vishal Agrawal
Chief Strat & Corp Dev Officer
161   Derivative/Non-derivative trans. at $459.85 per share. 74,035
12/15/2021 Vishal Agrawal
Chief Strat & Corp Dev Officer
184   Derivative/Non-derivative trans. at $459.85 per share. 84,612
12/15/2021 Joseph C Ventura
Chief Legal Officer
174   Derivative/Non-derivative trans. at $459.85 per share. 80,013
12/15/2021 Joseph C Ventura
Chief Legal Officer
144   Derivative/Non-derivative trans. at $459.85 per share. 66,218
12/15/2021 Joseph C Ventura
Chief Legal Officer
127   Derivative/Non-derivative trans. at $459.85 per share. 58,400
12/15/2021 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO
179   Derivative/Non-derivative trans. at $459.85 per share. 82,313
12/15/2021 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO
197   Derivative/Non-derivative trans. at $459.85 per share. 90,590
12/15/2021 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO
249   Derivative/Non-derivative trans. at $459.85 per share. 114,502
12/15/2021 William Shrank
Chief Medical Officer
156   Derivative/Non-derivative trans. at $459.85 per share. 71,736
12/15/2021 William Shrank
Chief Medical Officer
170   Derivative/Non-derivative trans. at $459.85 per share. 78,174
12/15/2021 Sue Schick
Seg Pres. Grp. & Military Bus.
87   Derivative/Non-derivative trans. at $459.85 per share. 40,006
12/15/2021 Sue Schick
Seg Pres. Grp. & Military Bus.
602   Derivative/Non-derivative trans. at $459.85 per share. 276,829
12/15/2021 Sue Schick
Seg Pres. Grp. & Military Bus.
74   Derivative/Non-derivative trans. at $459.85 per share. 34,028
12/15/2021 Bruce Dale Broussard
President & CEO; Director
2,464   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Bruce Dale Broussard
President & CEO; Director
2,673   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Bruce Dale Broussard
President & CEO; Director
3,045   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Timothy Alan Wheatley
Segment President, Retail
549   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Timothy Alan Wheatley
Segment President, Retail
570   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Timothy Alan Wheatley
Segment President, Retail
596   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Cynthia H. Zipperle
SVP, Chief Acct Officer & Cont
205   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Cynthia H. Zipperle
SVP, Chief Acct Officer & Cont
238   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Cynthia H. Zipperle
SVP, Chief Acct Officer & Cont
271   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Heather Cox
Chief Dig Health & Analyt Off.
328   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Heather Cox
Chief Dig Health & Analyt Off.
356   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Heather Cox
Chief Dig Health & Analyt Off.
406   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Susan M. Diamond
Chief Financial Officer
366   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Susan M. Diamond
Chief Financial Officer
285   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Susan M. Diamond
Chief Financial Officer
282   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Timothy S. Huval
Chief Administrative Officer
405   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Timothy S. Huval
Chief Administrative Officer
404   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Timothy S. Huval
Chief Administrative Officer
460   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Sam Deshpande
Chief Information Officer
350   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Sam Deshpande
Chief Information Officer
380   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Sam Deshpande
Chief Information Officer
406   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Vishal Agrawal
Chief Strat & Corp Dev Officer
328   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Vishal Agrawal
Chief Strat & Corp Dev Officer
356   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Vishal Agrawal
Chief Strat & Corp Dev Officer
406   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Joseph C Ventura
Chief Legal Officer
372   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Joseph C Ventura
Chief Legal Officer
309   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Joseph C Ventura
Chief Legal Officer
271   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO
389   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO
428   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 William Kevin Fleming
Seg Pres, Pharmacy Sol & CCAO
542   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 William Shrank
Chief Medical Officer
328   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 William Shrank
Chief Medical Officer
356   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Sue Schick
Seg Pres. Grp. & Military Bus.
189   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Sue Schick
Seg Pres. Grp. & Military Bus.
1,603   Derivative/Non-derivative trans. at $0 per share. 0
12/15/2021 Sue Schick
Seg Pres. Grp. & Military Bus.
238   Derivative/Non-derivative trans. at $0 per share. 0
12/11/2021 Vishal Agrawal
Chief Strat & Corp Dev Officer
285   Derivative/Non-derivative trans. at $455.64 per share. 129,857
12/11/2021 Vishal Agrawal
Chief Strat & Corp Dev Officer
811   Derivative/Non-derivative trans. at $0 per share. 0
11/05/2021 Bruce Dale Broussard
President & CEO; Director
8,721   Disposition at $457.4 per share. 3,988,985
11/05/2021 Bruce Dale Broussard
President & CEO; Director
41,285   Disposition at $454.13 per share. 18,748,757
11/05/2021 Bruce Dale Broussard
President & CEO; Director
26,939   Derivative/Non-derivative trans. at $307.96 per share. 8,296,134
11/05/2021 Bruce Dale Broussard
President & CEO; Director
14,346   Derivative/Non-derivative trans. at $268.47 per share. 3,851,470
/news/latest/company/us/hum

MarketWatch News on HUM

  1. Humana Inc. stock outperforms market on strong trading day

    4:58 p.m. May 20, 2022

    - MarketWatch Automation

  2. Humana Inc. stock outperforms competitors on strong trading day

    4:58 p.m. May 19, 2022

    - MarketWatch Automation

  3. Humana Inc. stock underperforms Wednesday when compared to competitors

    4:58 p.m. May 18, 2022

    - MarketWatch Automation

  4. Humana Inc. stock underperforms Tuesday when compared to competitors

    4:58 p.m. May 17, 2022

    - MarketWatch Automation

  5. The Experts Are Getting More Defensive on Stocks

    2:17 p.m. May 17, 2022

    - Barron's Online

  6. Humana Inc. stock rises Friday, still underperforms market

    4:58 p.m. May 13, 2022

    - MarketWatch Automation

  7. Humana Inc. stock falls Thursday, underperforms market

    4:58 p.m. May 12, 2022

    - MarketWatch Automation

  8. Humana Inc. stock falls Wednesday, still outperforms market

    4:58 p.m. May 11, 2022

    - MarketWatch Automation

  9. Humana Inc. stock outperforms competitors on strong trading day

    4:58 p.m. May 10, 2022

    - MarketWatch Automation

  10. Humana Inc. stock outperforms market despite losses on the day

    4:58 p.m. May 9, 2022

    - MarketWatch Automation

  11. Humana Inc. stock underperforms Friday when compared to competitors

    4:58 p.m. May 6, 2022

    - MarketWatch Automation

  12. Humana Inc. stock outperforms competitors despite losses on the day

    4:58 p.m. May 5, 2022

    - MarketWatch Automation

  13. Humana Inc. stock rises Wednesday, still underperforms market

    4:58 p.m. May 4, 2022

    - MarketWatch Automation

  14. Humana Inc. stock rises Tuesday, still underperforms market

    4:58 p.m. May 3, 2022

    - MarketWatch Automation

  15. Humana Inc. stock underperforms Monday when compared to competitors

    5:00 p.m. May 2, 2022

    - MarketWatch Automation

  16. Humana Inc. stock falls Friday, still outperforms market

    4:58 p.m. April 29, 2022

    - MarketWatch Automation

  17. Humana Inc. stock outperforms market on strong trading day

    4:58 p.m. April 28, 2022

    - MarketWatch Automation

  18. Loading more headlines...
/news/nonmarketwatch/company/us/hum

Other News on HUM

  1. 3 Top Healthcare Stocks to Buy for May

    8:15 a.m. May 5, 2022

    - Motley Fool

  2. 10-Q: HUMANA INC

    2:25 p.m. April 27, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  3. Humana: Valuation Looks Fair, Some Risks Ahead

    9:58 p.m. April 26, 2022

    - Seeking Alpha

  4. Humana Q1 2022 Earnings Preview

    12:07 p.m. April 26, 2022

    - Seeking Alpha

  5. Notable earnings before Wednesday's open

    10:51 a.m. April 26, 2022

    - Seeking Alpha

  6. Is This Value Stock a Buy?

    10:45 a.m. April 22, 2022

    - Motley Fool

  7. 3 Top Dividend Growth Stocks to Buy Right Now

    10:23 a.m. April 20, 2022

    - Motley Fool

  8. Oakmark Select Fund: Q1 2022 Commentary

    12:55 p.m. April 19, 2022

    - Seeking Alpha

  9. Humana upgraded to buy at UBS on membership growth rebound

    10:26 a.m. April 13, 2022

    - Seeking Alpha

  10. My Top 15 High Growth Dividend Stocks For April 2022

    9:03 a.m. April 6, 2022

    - Seeking Alpha

  11. High-Growth Primary Care Stocks Investors Should Consider Now

    9:10 a.m. April 5, 2022

    - Baystreet.ca

  12. Loading more headlines...

At a Glance

Humana, Inc.

500 West Main Street

Louisville, Kentucky 40202

Phone

1 5025801000

Industry

Life Insurance

Sector

Financial Services

Fiscal Year-end

12/2022

Revenue

$83.65B

Net Income

$2.93B

Employees

96,900

/news/pressrelease/company/us/hum

Press Releases on HUM

  1. Humana (HUM) Trading Report

    3:47 p.m. May 17, 2022

    - Stock Traders Daily

  2. Trend Tracker for Humana HUM

    10:23 p.m. May 7, 2022

    - Stock Traders Daily

  3. Humana Inc. to Present at the BofA Securities 2022 Healthcare Conference

    4:30 p.m. April 28, 2022

    - BusinessWire - BZX

  4. Humana HUM Trading Signals

    5:46 a.m. April 28, 2022

    - Stock Traders Daily

  5. Humana Board Declares Payment of Quarterly Dividend to Stockholders

    6:30 a.m. April 21, 2022

    - BusinessWire - BZX

  6. When Humana (HUM) Moves Investors should Listen

    12:57 p.m. April 18, 2022

    - Stock Traders Daily

  7. Humana HUM Trading Signals

    7:10 p.m. April 8, 2022

    - Stock Traders Daily

  8. Humana HUM Trading Report

    1:27 a.m. March 30, 2022

    - Stock Traders Daily

  9. Loading more headlines...
Link to MarketWatch's Slice.